Imagine what would happen if an RCT was conducted with Remestemcel for aGVHD and it again failed to show efficacy? That would be strong motivation for everyone who has staked their careers, reputation and personal fortunes on it's supposed therapeutic effects to want to avoid a definitive judgement day...
- Forums
- ASX - By Stock
- banter and General Discussion
Imagine what would happen if an RCT was conducted with...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B |
Open | High | Low | Value | Volume |
$1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | $1.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 133644 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5951 | 1.515 |
2 | 25946 | 1.510 |
3 | 69790 | 1.505 |
10 | 85830 | 1.500 |
5 | 49557 | 1.495 |
Price($) | Vol. | No. |
---|---|---|
1.520 | 133644 | 5 |
1.525 | 36900 | 5 |
1.530 | 108768 | 5 |
1.535 | 48010 | 6 |
1.540 | 113241 | 11 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online